As a consequence, the true HR would potentially be more in favor of GLP-1 RAs than the HRs observed in this study
Walking 30 minutes daily after meals also helps with digestion and reduces gastrointestinal side effects
Red Flags Nausea on GLP-1 Therapy: When It Is a Dose Issue and When It Needs Attention Nausea is one of the most common side effects patients ask about during GLP-1 therapy
Stronger mechanistic clarification would require isoform-specific NOS inhibition, direct measurement of NO metabolites, eNOS phosphorylation analysis, rescue experiments, and comparison across endothelial, epithelial, fibroblast, and neuronal model systems
Efficacy Results of a SURPASS open-label, phase III trial, published in 2021, demonstrated tirzepatides superior glycaemic efficacy and weight reduction compared with existing GLP-1 receptor agonists, including semaglutide 6